US to test benefits of remdesivir with second drug

This post was originally published on this site

The U.S. has begun the third phase of its remdesivir study, testing the antiviral drug’s effectiveness in treating COVID-19 when taken alongside beta interferon, another antiviral and anti-inflammatory drug. During the trial, 1,000 COVID-19 patients will receive …

Click here to read full article